STONY BROOK, NY. September 1, 2015. Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, product genotyping and product authentication solutions, announced today that it has achieved ISO/IEC 17025:2005 Accreditation for the Examination and Analysis of CViT(cash/valuables-in-transit) and Asset Protection products, utilizing Fragment Length Polymorphism from ANSI-ASQ National Accreditation Board (ANAB).

ISO 17025 is a global standard applicable for testing laboratories that is based on a comprehensive review of a laboratory’s quality system, technical competence and performance to ensure it produces accurate, precise, and consistent results. Applied DNA Sciences stands at the forefront of DNA-based technologies, and achieving ISO/IEC 17025:2005 accreditation is an example of the company’s commitment to the highest quality scientific standards.

Dr. Ila Lansky, Senior Forensic Scientist of Applied DNA Sciences, stated: “This accreditation confirms what we have known all along, Applied DNA Sciences provides its clients the highest quality and reliable scientific results. Customers can be confident that their products are tested against industryaccepted criteria using methods that objectively determine a products origins forensically.”

Factors assessed by the accreditation bodies include technical competence of staff, validity of test methods, measurement traceability, maintenance of test equipment, testing environment, handling of test items and quality assurance of test data.

About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the platform ingredient that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of uncopyable products such as DNAnet® , our antitheft product, SigNature® T and fiberTyping® , targeted toward textiles, and digitalDNA® , providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators. Applied DNA Sciences common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.

Forward Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 15, 2014, as amended on March 6, 2015, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2015, May 11, 2015 and August 10, 2015, which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Investor contact: Debbie Bailey, 631-240-8817, debbie.bailey@adnas.com
media contact: Dian Griesel Int’l., 212-825-3210, dian@dgicomm.com
web: www.adnas.com
twitter: @APDN